BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 10896986)

  • 21. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of patients with myasthenia gravis.
    Sanders DB; Scoppetta C
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myasthenia gravis].
    Fleury MC; Tranchant C
    Rev Prat; 2008 Dec; 58(20):2217-24. PubMed ID: 19209651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myasthenia gravis].
    Tanaka K
    Nihon Rinsho; 2004 May; 62 Suppl 5():580-5. PubMed ID: 15197988
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of autoimmune myasthenia gravis.
    Richman DP; Agius MA
    Neurology; 2003 Dec; 61(12):1652-61. PubMed ID: 14694025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
    Gajdos P; Chevret S
    Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenic crisis after a renal transplant successfully treated with intravenous immunoglobulin.
    Hwang IH; Lee KN; Kim IY; Lee DW; Lee SB; Kim DS; Song SH; Seong EY; Kwak IS
    Exp Clin Transplant; 2014 Dec; 12(6):555-8. PubMed ID: 24568644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of myasthenia gravis].
    Rilling G; Tettenborn B
    Praxis (Bern 1994); 2001 Aug; 90(33):1350-4. PubMed ID: 11534319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of autoimmune myasthenia].
    PĂ©nisson-Besnier I
    Rev Neurol (Paris); 2010 Apr; 166(4):400-5. PubMed ID: 19836041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary treatment for prepubertal juvenile myasthenia gravis with crisis.
    Hirata Y; Inoue M; Nabatame S; Okumura M; Ozono K
    Pediatr Int; 2016 Aug; 58(8):772-4. PubMed ID: 27324449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.
    Lagoumintzis G; Zisimopoulou P; Kordas G; Lazaridis K; Poulas K; Tzartos SJ
    Autoimmunity; 2010 Aug; 43(5-6):436-45. PubMed ID: 20187712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M; Taiuti R; Marconi G
    Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
    Ferrero B; Durelli L
    Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis: emerging new therapy options.
    Sieb JP
    Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune myasthenia gravis.
    Gilhus NE
    Expert Rev Neurother; 2009 Mar; 9(3):351-8. PubMed ID: 19271944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment principles in the management of autoimmune myasthenia gravis.
    Richman DP; Agius MA
    Ann N Y Acad Sci; 2003 Sep; 998():457-72. PubMed ID: 14592915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.